The accuracy of self-reported hypertension: A systematic review and meta-analysis

Current Hypertension Reviews

Volumn 4, Issue 1, 2008, Pages 36-62

  Gorber, Sarah Connor ^a   Tremblay, Mark ^a   Campbell, Norm ^b   Hardt, Jill ^a  

^a STATISTICS CANADA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Blood pressure; Direct measure; Hypertension awareness; Self report; Systematic review

Indexed keywords

ACCURACY; AWARENESS; BLOOD PRESSURE MEASUREMENT; CLINICAL PROTOCOL; DATA BASE; DIAGNOSTIC VALUE; ELECTRONIC MEDICAL RECORD; EXPERIMENTAL STUDY; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; QUANTITATIVE STUDY; REVIEW; SELF REPORT; STANDARDIZATION; SYSTEMATIC REVIEW;

EID: 39349093828     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340208783497192     Document Type: Review

References (176)

1. Green MS, Peled I. Prevalence and control of hypertension in a large cohort of occupationally-active Israelis examined during 1985-1987: the Cordis Study. Int J Epidemiol 1992; 21: 676-82.
2. Gu D, Reynolds K, Wu X, et al. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40: 920-7.
3. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens 2001; 19: 1523-32.
4. World Health Organization. The World Health Report 2002, Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization Geneva; 2002.
5. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-84.
6. Saunders DL, Soomro GM, Buckingham J, Jamtvedt G, Raina P. Assessing the methodological quality of nonrandomized intervention studies. West J Nurs Res 2003; 25: 223-37.
7. Decks JJ, Dinnes J, D'Amico R, et al. Evaluating non randomized intervention studies. Health Technol Assess 2003; 7: 1-173.
8. Campbell NRC, Joffres MR, McKay DW. Hypertension Surveillance in Canada. Minimum Standards for Assessing Blood Pressure in Surveys. Can J Public Health 2005; 96: 217-20.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
10. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
11. Burt VL, Cutler JA, Higgins M. et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-9.
12. Glover MJ, Greenlund KJ, Ayala C, Croft JB. Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1992-2002. JAMA 2005; 293: 923-5.
13. Pappas G, Gergen PJ, Carroll M. Hypertension prevalence and the status of awareness, treatment, and control in the Hispanic Health and Nutrition Examination Survey (HHANES), 1982-84. Am J Public Health 1990; 80: 1431-6.
14. Alonso A, Beunza JJ, Delgado-Rodriguez M, Martinez-Gonzalez MA. Validation of self reported diagnosis of hypertension in a cohort of university graduates in Spain. BMC Public Health 2005; 5.
15. Abernethy JD. The Australian National Blood Pressure Study. Med J Aust 1974; 1: S21-4.
16. Astagneau P, Lang T, Delarocque E, Jeannee E, Salem G. Arterial hypertension in urban Africa: an epidemiological study on a representative sample of Dakar inhabitants in Senegal. J Hypertens 1992; 10: 1095-1101.
17. Altun B, Arici M, Nergizoglu G, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005; 23: 1817-23.
18. Achananuparp S, Suriyawongpaisal P, Suebwonglee S, et al. Prevalence, detection and control of hypertension in Thai population of a central rural community. J Med Assoc Thai 1989; 72: 66-75.
19. Amoah AGB. Hypertension in Ghana: A cross-sectional community prevalence study in Greater Accra. Ethn Dis 2003; 13: 310-15.
20. Arroyo P, Fernandez V, Loria A, et al. Hypertension in urban Mexico: The 1992-93 national survey of chronic diseases. J Hum Hypertens 1999; 13: 671-5.
21. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Hum Hypertens 2002; 16: 305-12.
22. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: Distribution, awareness, control, and benefits of a reduction in average pressure. J Hypertens 1998; 32: 998-1002.
23. Banegas JR, Rodriguez-Artalejo F, Ruilope LM, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens 2002; 20: 2157-64.
24. Bharucha NE, Kuruvilla T. Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment. BMC Public Health 2003; 3.
25. Birkett NJ, Donner AP, Maynard M. Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance. Can Med Assoc J 1987; 136: 595-600.
26. Birkett NJ, Donner AP, Maynard M. Prevalence and control of hypertension in an Ontario county. Can Med Assoc J 1985; 132: 1019-24.
27. Birkett NJ, Evans CE, Haynes RB, et al. Hypertension control in two Canadian communities: evidence for better treatment and over-labelling. J Hypertens 1986; 4: 369-74.
28. Birkett, NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens 1997; 15: 237-44.
29. Brindel P, Hanon O, Dartigues J-F, et al. Prevalence, awareness, treatment, and control of hypertension in the elderly: The Three City study. J Hypertens 2006; 24: 51-8.
30. Brown DJ, Metiko EB. Prevalence of hypertension in a sample of black American adults using JNC 7 classifications. J Natl Black Nurses Assoc 2005; 16: 1-5.
31. Bowlin SJ, Morrill BD, Nafziger AN, Jenkins PL, Lewis C, Pearson TA. Validity of cardiovascular disease risk factors assessed by telephone survey: The behavioral risk factor survey. J Clin Epidemiol 1993; 46: 561-71.
32. Campbell NR, Jeffrey P, Kiss K, Jones C, Anton AR. Building capacity for awareness and risk factor identification in the community: the blood pressure assessment program of the Calgary Fire Department. Can J Cardiol 2001; 17: 1275-79.
33. Cappuccio FP, Micah FB, Emmett L, et al. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension 2004; 43: 1017-22.
34. Carter-Edwards L, Jackson SA, Runaldue MJ, Svetkey LP. Diet-and blood pressure related knowledge, attitudes, and hypertension prevalence among African Americans: the KDBp Study. Knowledge of Diet and Blood Pressure. Ethn Dis 2002, 12: S1-82.
35. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N. Prevalence, awareness and treatment status of hypertension, in urban populations of Delhi. Indian J Med Res 1990; 92: 233-40.
36. Chen CH, Lin HC, Kuo HS, Chang, MS, Chou P. Epidemiology of hypertension in kin-Hu, Kinmen. Am J Hypertens 1995; 8: 395-403.
37. Chen R, Tunstall-Pedoe H, Morrison C, Connaghan J, A'Brook R. Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited. J Hum Hypertens 2003; 17: 751-9.
38. Choi KM, Park HS, Han JH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens 2006; 24: 1515-21.
39. Chua B, Roohtchina E, Mitchell P. Temporal changes in the control of blood pressure in an older Australian population. J Hum Hypertens 2005; 19: 691-6.
40. Cifkova R, Skodova Z, Lanska V, et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys, in 1997/1998 and 2000/2001, Czech Post-MONICA study. J Hum Hypertens 2004; 18; 5571-9.
41. Colhoun HM, Dong W, Boulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747-52.
42. De Backer G, Myny K, De Henauw S, et al. Prevalence awareness, treatment and control of arterial hypertension in an elderly population in Belgium. J Hum Hypertens 1998; 12: 701-6.
43. De Henauw S, De Bacquer D, Fonteyne W, Stam M, Komitzer M, De Backer G. Trends in the prevalence, detection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens 1998; 16: 277-84.
44. Deprez RD, Miller E, Hart SK. Hypertension prevalence among Penobscot Indians of Indian Island, Maine. Am J Pub Health 1985; 75: 653-4.
45. Dickson BK, Blackledge J, Hajjar IM. The impact of lifestyle behavior on hypertension awareness, treatment, and control in a southeastern population. Am J Med Sci 2006; 332: 211-15.
46. Duprez D, Van Helshoecht, Van den Eynde W, Leeman M. Prevalence of hypertension in the adult population of Belgium: report of a worksite study. Attention Hypertension. J Hum Hypertens 2002; 16: 47-52.
47. Efstratopoulos AD, Voyaki SM, Baltas AA, et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: The Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006; 19: 53-60.
48. Entwisle G, Scott JC, Apostolides AY, et al. A survey of blood pressure in the state of Maryland. Prev Med 1983; 12: 695-708.
49. Fodor JG, Lietava J, Rieder A, et al. Work-site hypertension prevalence and control in three Central European countries. J Hum Hypertens 2004; 18: 591-5.
50. Foster C, Rotimi C, Fraser H, et al. Hypertension, diabetes, and obesity in Barbados: findings from a recent population-based survey. Ethn Dis 1993; 3: 404-12.
51. Franco LJ, Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Comeaux PJ. Prevalence, detection, and control of bypertension in a biethnic community: the San Antonio Health Study. Am J Epidemiol 1985; 121 684-96.
52. Freeman V, Fraser H, Forrester T, et al. A comparative study of hypertension prevalence, awareness, treatment and control rates in St Lucia, Jamaica and Barbados. J Hypertens 1996; 14: 495-501.
53. Freeman Jr DH, Ostfeld AM, Hellenbrand K, Richards VA, Tracy R. Changes in the prevalence distribution of hypertension: Connecticut adults 1978-79 to 1982. J Chrob Dis 1985; 38: 157-64.
54. Furumoto-Dawson AA, Pandey DK, Elliott WJ, et al. Hypertension in women: The women take heart project. J Clin Hypertens 2003; 5: 38-46.
55. Garbus SB, Garbus SB. Analysis of mass hypertension screening. Prev Med 1976; 5: 48-59.
56. Garcia-Pena C, Thorogood M, Reyes S, Salmeron-Castro J, Duran C. The prevalence and treatment of hypertension in the elderly population of the Mexican Institute of Social Security Salud Publica Mex 2001; 43: 415-20.
57. Gasse C, Hense H-W, Stieber J, Doring A, Liese AD, Keil U. Assessing hypertension management in the community: Trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 2001; 15: 27-36.
58. Gelberg L, Linn LS. Assessing the physical health of homeless adults. JAMA 1989; 262: 1973-9.
59. Gentleman J, Tomiak M. The consistency of various high blood pressure indicators based on questionnaire and physical measures data from the Canada Health Survey. Health Rep 1992; 4: 293-311.
60. Getliffe KA, Crouch R, Gage H, Lake F, Wilson SL. Hypertension awareness, detection and treatment in a university community: Results of a worksite screening. Public Health 2000; 114: 361-6.
61. Giles WH, Croft JB, Keenan NL. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt. Am J Prev Med 1995; 11: 163-9.
62. Gonzalez-Villalpando C, Stern MP, Haffner SM, Gonzalez Villapando ME, Gaskill S, Martinez DR. Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. J Cardiovasc Risk 1999; 6: 177-81.
63. Goldman N, Lin I-F, Weinstein M, Lin Y-H. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol 2003; 56: 148-54.
64. Guimaraes AC. Hypertension in Brazil. J Hum Hypertens 2002; 16: S7-10.
65. Halabi S, Zurayk H, Awaida R, Darwish M, Saab B. Reliability and validity of self and proxy reporting of morbidity data: A case study from Beirut, Lebanon. Int J Epidemiol 1992; 21: 607-12.
66. Handa SP, Roma S, Brewer H. Prevalence of hypertension: a screening survey in an adult population. Can J Public Health 1980; 71: 171-5.
67. Health and Welfare Canada. Main Findings Report of the Canadian Blood Pressure Survey. Ottawa: Department of National Health and Welfare; 1989.
68. Hennis A, Wu S-Y, Nemesure B, Leske MC. Hypertension prevalence control and survivorship in an Afro-Caribbean population. J Hypertens 2002; 20: 2363-9.
69. Holmen J, Forsen L, Hjort PF, Midthjell, Waaler HT, Bjorndal A. Detecting hypertension: screening versus case finding in Norway. Br Med J 1991; 302: 219-22.
70. Holtzman E, Goldbourt U, Rosenthal T, Yaari S, Neufeld HN. Hypertension in middle-aged men: associated factors and mortality experience. Isr J Med Sci 1983; 19: 25-33.
71. Howteerakul N, Suwannapong N, Sittilerd R, Rawdaree P. Health risk behaviours, awareness, treatment and control of hypertension among rural community people in Thailand. Asia Pac J Public Health 2006; 18: 3-9.
72. Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities: a two-stage screen for hypertension. JAMA 1977; 22: 2385-91.
73. Ibrahim MM, Rizk H, Appel LJ, et al. Hypertension prevalence, awareness, treatment and control in Egypt: results from the Egyptian National Hypertension Project (NHP). Hypertension 1995; 26: 886-90.
74. Jamrozik K, Hockey R. Trends in risk factors for vascular disease in Australia. Med J Aust 1989; 150: 14-8.
75. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10: 1097-1102.
76. Johansson J, Hellenius M-L, Elofsson S, Krakau I. Self-report as a selection instrument in screening for cardiovascular disease risk. Am J Prev Med 1999; 16: 322-4.
77. Johnson CC, Powers NR, Bao W, Harsha DW, Berenson GS. Cardiovascular risk factors of elementary school teachers in a low socio-economic area of a metropolitan city: The Heart Smart Program. Health Educ Res 1994; 9: 183-91.
78. Jones DW, Kim JS, Kim SJ, Hong YP. Hypertension awareness, treatment and control rates for an Asian population: results from a national survey in Korea. Ethn Health 1996; 1: 269-73.
79. Jones RAP, Ricard R, Sefcik E, Miller ME. The health risk of hypertension in South Texas: a demographic profile. Holist Nurs Pract 2001; 15: 35-44.
80. Kalatan KA, Mohamed AG, Al-Taweel AA, Ghani HMA. Hypertension among attendants of primary health-care centers in Al-Qassim region, Saudia Arabia. Saudi Med J 2001; 22: 960-3.
81. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya J-C. Prevalence, awareness and management of hypertension in Cameroon: Findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens 2006; 20: 91-2.
82. Kastarinen MJ, Antikainen RL, Laatikainen TK, et al. Trends in hypertension care in eastern and south-western Finland during 1982-2002. J Hypertens 2006; 24: 829-36.
83. Kattainen A, Reunanen A, Koskinen S, Martelin T, Knekt P, Aromaa A. Secular changes in prevalence of cardiovascular diseases in elderly Finns. Scand J Public Health 2002; 30: 274-80.
84. Klungel OH, De Boer A, Paes AHP, Nagelkerke NJD, Seidell JC, Bakker A. Influence of correction for within-person variability in blood pressure on the prevalence, awareness, treatment, and control of hypertension. Am J Hypertens 2000; 13: 88-91.
85. Lang T, de Gaudemaris R, Chatellier G, Harnici L, Diene E. Prevalence and therapeutic control of hypertension in 30 000 subjects in the workplace. Hypertension 2001; 38: 449-54.
86. Leynen F, De Backer H, Pelfrene, E, et al. Increased absenteeism from work among aware and treated hypertensive and hypercholesterolaemic patients. Euj J Cardiovasc Prev Rehabil 2006; 13: 261-7.
87. Li W, Jiang X, Ma H, et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens 2003; 21: 1191-7.
88. Lima-Costa MF, Peixoto SV, Firmo JOA. Validity of self-reported hypertension and its determinants (the Bambui study). Rev Saude Publica 2004; 38: 637-42.
89. Lin T, Chen C-H, Chou P. A hypertension control program in Yu-Chi, Taiwan: Preliminary results. J Formos Med Assoc 1997; 96; 613-20.
90. Lisk DR, Williams DE, Slattery J. Blood pressure and hypertension in rural and urban Sierra Leoneans. Ethn Dis 1999; 9: 254-63.
91. M'Buyamba-Kabangu J-R, Fagard R, Lijnen P, et al. Epidemiological study of blood pressure and hypertension in a sample of urban Bantu of Zaire. J Hypertens 1986; 4: 485-91.
92. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J. Hypertension prevalence, awareness, treatrnent, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 2005; 28: 301-6.
93. Macedo ME, Lima MJ, Silva AO, et al. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens 2005; 23: 1661-6.
94. Matenga JA, Allain TJ, Wilson AO, et al. Hypertension management in Zimbabwe - awareness, treatment and blood pressure control. SAMJ. 1997; 87:1371-3.
95. Mancia G, Parati G, Borghi C, et al. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: The SMOOTH study. J Hypertens 2006; 24: 837-43.
96. Meisner I, Whisnant JP, Sheps SG, et al. Detection and control of high blood pressure in the community: do we need a wake-up call? Hypertension 1999; 34:466-71.
97. Metcalf CA, Hoffman MN, Steyn K, Katzenellenbogen JM, Fourie JM. Design and baseline characteristics of a hypertension intervention program in a South African village. J Hum Hypertens 1996; 10: 21-6.
98. Mosca L, Edelman D, Mochari H, Christian AH, Paultre F, Pollin I. Waist circumference predicts cardiometabolic and Global Framingham Risk among women screened during National Woman's Heart Day. J Womens Health 2006; 15: 24-34.
99. Muntner P, Gu D, Wu X, et al. Factors Associated with Hypertension Awareness, Treatment, and Control in a Representative Sample of the Chinese Population. Hypertension 2004; 43: 578-85.
100. Nan L, Tuomilehto J, Dowse G, et al. Prevalence and medical care of hypertension in four ethnic groups in the newly-industrialized nation of Mauritius. J Hypertens 1991; 9: 859-66.
101. Nieto FJ, Alonso, J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1995; 155: 677-84.
102. Nissinen A, Tuomilehto J, Korhonen HJ, Piha T, Salonen JT, Puska P. Ten-year results of hypertensioncare in the community: follow-up of the North Karelia Hypertension Control Program. Am J Epidemiol 1988; 127: 488-99.
103. Nova Scotia Department of Health. The Nova Scotia Health Survey, 1995. Nova Scotia: Communications Nova Scotia; 1996.
104. de Pablos-Velasco P, Martinez-Martin FJ, Perez FR, Urioste LMR, Robles a RG. Prevalence, awareness, treatment and control of hypertension in a Canarian population. Relationship with glucose tolerance categories. The Guia study. J Hypertens 2002; 20:.1965-71.
105. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: Results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001; 15: 793-98.
106. Panagiotakos DB, Pitsavos CH, Chrysohoou C, et al. Status and manggement of hypertension in Greece: Role of the adoption of a Mediterranean diet: The Attica study. J Hypertens 2003; 21: 1483-89.
107. Paschal AM, Lewis RK, Martin A, Dennis-Shipp D, Simpson DS. Baseline assessment of the health status and health behaviors of African Americans participating in the activities-for-tife program: A community-based health intervention program. J Community Health 2004; 29: 305.
108. Pavlik VN, Hyman DJ, Vallbona C, et al. Hypertension awareness adn control in an inner-city African-American sample. J Hum Hypertens 1997; 11: 277-83.
109. Pica LA, Boucher MM, Grignon R. The prevalence, awareness and control of hypertension in Laval, Quebec, 1986. Can J Public Health 1990; 81: 427-30.
110. Plans P, Pardell H, Salleras LI. Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol 1993; 9: 381-89.
111. Prencipe M, Casini AR, Santini M, Ferretti C, Scaldaferri N, Culasso F. Prevalance, awareness, treatment and control of hypertension in the elderly: Results from a population survey. J Hum Hypertens 2000; 14: 825-30.
112. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the Health Survey for England 1998. Hypertension 2001; 38: 827-32.
113. Primatesta P, Poulter NR. Improvements in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24: 1187-92.
114. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004; 33: 1345-52.
115. Puras A, Sanchis C, Artiago LM, Divison JA. Prevalence, awareness, treatment and control of hypertension in a Spanish population. Eur J Epidemiol 1998; 14: 13-36.
116. Ramirez MOA, Pino CT, Furiasse LVA, Lee AJ, Fowkes FGR. Paraguayan National Blood Pressure study: prevalence of hypertension in the general population. J Hum Hypertens 1995; 9: 891-97.
117. Reiff M, Schwartz S, Northridge M. Relationship of depressive symptoms to hypertension in a household survey in Harlem. Psychosom Med 2001; 63: 711-21.
118. Ruixing Y, Limei Y, Yuming C, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res 2006; 29: 423-32.
119. Rywik SL, Davis CE, Pajak A, et al. Poland and U.S. collaborative study on cardiovascular epidemiology hypertension in the community: prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA project and the U.S. atherosclerosis risk in communities study. Ann Epidemiol 1998; 8: 3-13.
120. Sarifidis PA, Lasaridis A, Gousopoulos S, et al. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: The Naoussa study, J Hum Hypertens 2004; 18: 623-29.
121. Satish S, Markides KS, Zhang D, Goodwin JS. Factors influencing unawareness of hypertension among older Mexican Americans. Prev Med 1997; 26: 645-50.
122. Schoenberger JA, Stamler J, Shekelle RB, Shekelle S. Current status of hypertension control in an industrial population. JAMA 1972; 222: 659-62.
123. Schmitz N, Thefeld W, Kruse J. Mental disorders and hypertension: Factors associated with awareness and treatment of hypertension in the general population of Germany. Psychosom Med 2006; 468: 246-52.
124. Sekikawa A, Hayakawa T. Prevalence of hypertension, its awareness and control in adult population in Japan (Research Letter). J Hum Hypertens 2004; 18: 911-12.
125. Shapiro M, Bleho J, Curran M, et al. Problems in the control of hypertension in the community. CMAJ 1978; 118: 37-9.
126. Sharma AM, Wittchen H-U, Kirch W, et al. High prevalence and poor control of hypertension in primary Care: Cross-sectional study. J Hypertens 2004; 22: 479-86.
127. Shoudi T, Xigui W, Xiufang D, et al. Hypertension prevalence and status of awareness treatment and control in China. Chin Med 1995; 108: 483-9.
128. Silverberg DS, Smith SO, Juchli B, VanDorsser E. Use of shopping centres in screening for hypertension CMAJ 1974; 111: 769-74.
129. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. Br Med J 1990; 300: 981-3.
130. Sonkodi B, Fodor JG, Abraham G, et al. Hypertension screening in a salami factory: A work rite hypertension study. J Hum Hypertens 2004; 18: 567-9.
131. Sonmez HM, Basak O, Camci C, et al. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydih Turkey. J Hum Hypertens 1999; 13: 399-404.
132. Spencer J, Phillips E, Ogedegbe G. Knowledge attitudes, beliefs, and blood pressure control in a community-based samole in Ghana. Ethn Dis 2005; 15.
133. Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans: Community Hypertension Evaluation Clinic (CHEC) Program, 1973 through 1975. JAMA 1976; 235: 2299-2306.
134. Stein AD, Stoyanovsky V, Mincheva V, et al. Prevalence, awareness, treatment and control of hypertension in a working Bulgarian population. Eur J Epidemiol 2000; 16: 265-70.
135. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD. Prevalence, awareness, treatment and control of hypertension in Greece: The Didima study. Am J Hypertens 1999; 12: 959-65.
136. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001; 19: 1717-25.
137. Takala J. Screening for hypertension in a middle-aged population in Southwest Finland. Prev Med 1978; 7: 230-44.
138. Tormo MJ, Navarro C, Chirlaque MD, Barber X, the EPIC Group of Spain. Is there a different dietetic pattern depending on self-knowledge of higb blood pressure? Eur J Epidemiol 2000; 16: 963-71.
139. Trenkwalder P, Ruland D, Stender M, et al. Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: Results from the Starnberg Study an epidemiology of Parkinsonism and hypertension in the elderly (STEPHY). J Hypertens 1994; 12: 709-16.
140. Aytekin NT, Pala K, Irgil E, Akis N, Aytekin H. Distribution of blood pressures in Gemlik District, North-West Turkey. Health Soc Care Community 2002; 10: 394-401.
141. Vaccarino V, Borgatta A, Gallus G, Sirtori CR. Prevalence of coronary heart disease risk factors in Northern-Italian male and female employees. Eur Heart J 1995; 16: 761-9.
142. van Rossum CTM, van de Mheen H, Witteman JCM, Hofman A, Mackenbach JP, Grobbee DE. Prevalence, treatment and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension 2000; 35: 814-21.
143. Wagner EH, James SA, Beresford SAA, et al. The Edgecombe County high blood pressure control program: correlates of uncontrolled hypertension at baseline. Am J Public Health 1984; 74: 237-42.
144. Wander GS, Khurana SB, Gulati R, et al. Epidemiology of coronary heart disease in a rural Punjab population-prevalence and correlation with various risk factors. Indian Heart J 1994; 46: 319-23.
145. Welty TK, Rhoades DA, Yeh F, et al. Changes in cardiovascular disease risk factors among American Indians: the Strong Heart Study. Ann Epidemiol 2002; 12: 97-106.
146. Wilber JA. The problem of undetected and untreated hypertension in the community. Bull NY Acad Med 1973; 49: 510-20.
147. Wilson TW, Dubois M, Ramsden V, Raina, P, Tan LK. The Saskatchewan heart foundation blood pressure survey. Can Fam Physician 1991; 37: 623-8.
148. Wolf HK, Andreou P, Bata IR, et al. Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995. CMAJ 1999; 161: 699-704.
149. Wolffsohn JS, Napper GA, Ho SM, et al. Improving the description of the retinal vasculature and patient history taking for monitoring systemic hypertension. Ophthalmic Physiol Opt 2001; 21: 441-9.
150. Wood DM, Jones KD. Comparing NHANES data in the assessment of hypertension of African Americans: awareness, treatment and control of hypertension in an urban Maryland city. Md Med 2002: 57-9.
151. Zdrojewski T, Wyrzykowski B, Szczech R, et al. Epidemiology and prevention of arterial hypertension in Poland. Blood Press 2005; 14: 10-16.
152. Zrojewski T, Wyrzykowski B, Wierucki L, et al. Attempt to eliminate health inequalities in Poland arising at the time of political and economic transformation: Polish 400 Cities Project. Eur J Cardiovase Prev Rehabil 2006; 13: 832-8.
153. Banegas JR, Guallar-Castillon P, Rodriguez-Artalejo F, Graciani A, Lopez-Garcia E, Ruilope LM. Association Between Awareness, Treatment and Control of Hypertension, and Quality of Life Among Older Adults in Spain. Am J Hypertens 2006; 19: 686-93.
154. Stewart JC, France CR, Sheffield D. Hypertension awareness and pain reports: Data from the NHANES III. Ann Behav Med 2003; 26: 8-14.
155. Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 2005; 46: 263-9.
156. Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988-1994. Am J Prev Med 2002; 22: 42-8.
157. Barger SD, Muldoon MF. Hypertension labelling was associated with poorer self-rated health in the Third US National Health and Nutrition Examination Survey. J Hum Hypertens 2006; 20: 117-23.
158. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation 2006; 113: 213-21.
159. Vargas CM, Burt VL, Gillum RF, Pamuk ER. Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. Prev Med 1997; 26: 678-85.
160. Hajjar I, Kotchen TA. Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
161. Roccella EJ. Hypertension prevalence and the status of awareness, treatment, and control in the United States. Hypertension 1985; 7: 457-68.
162. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 2005; 25: 305-13.
163. Mulrow PJ. Detection and control of hypertension in the population the United States Experience. Am J Hypertens 1998; 11: 744-6.
164. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-86.
165. Ford ES, Harel Y, Heath G, Cooper RS, Caspersen CJ. Test characteristics of self-reported hypertension among the Hispanic population: Findings from the Hispanic Health and Nutrition Examination Survey. J Clin Epidemiol 1990; 43: 159-65.
166. O'Brien E, Asmar R, Bellin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21; 821-48.
167. U.S. Department of Health and Human Services. JNC Express. The Seventh Report on the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Institute of Health, NIH Publication No. 03-5233: 2003.
168. Abbott D, Campbell N, Carruthers-Czyzewski P, et al. Guidelines for measurement of blood pressure follow-up and lifestyle counseling Can J Public Pealth 1994; 85: S29-35.
169. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000; 49: 147-52.
170. Solberg LI, Kottke TE, Brekke ML. Variation in clinical preventive services Eff Clin Pract 2001; 4: 121-6.
171. Heymann AD, Hoch I, Valinsky L, Shalev V, Silber H and Kokia E. Mandatory computer field for blood pressure measurement improves screening. Fam Pract 2005; 22: 168-9.
172. Kitai E, Vinker S, Halperin L, Meidan A, Grossman E. Pre-hypertension is a common phenomenon: national database study. Isr Med Assoc J 2007; 9: 8-11.
173. Agyemang C, van Valkengoed I, Koopmans R, Stronks K. Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, The Netherlands: The SUNSET study. J Hum Hypertens 2006; 20: 874-81.
174. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals part 1: Blood pressure measurement in humans: A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-61.
175. Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H and the European Health Risk Monitoring Project. Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys. Helsinki: The Finnish National Public Health Institute; 2002.
176. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24: 423-30.